Bulletin
Investor Alert

Alder BioPharmaceuticals Inc.

NAS: ALDR

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210439198/composite

$

18.90

Change

0.00 0.00%

Volume

Volume 5,661

Oct 17, 2019, 4:41 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210439198/composite

Today's close

$ 18.87

$ 18.90

Change

+0.03 +0.16%

Day low

Day high

$18.86

$18.91

Open
Open: 18.88

52 week low

52 week high

$8.39

$18.99

Open

Market cap

$1.58B

Average volume

3.54M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-4.45

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/aldr

MarketWatch News on ALDR

  1. Alder BioPharmaceuticals downgraded to market perform at BMO Capital

    10:07 a.m. Sept. 17, 2019

    - Tomi Kilgore

  2. Alder BioPharmaceuticals upgraded to neutral from sell at UBS

    9:21 a.m. Sept. 17, 2019

    - Tomi Kilgore

  3. Making the Case for a Biogen Deal, and 3 Potential Targets

    7:15 a.m. May 30, 2019

    - Barron's Online

  4. These 6 biotech stocks are promising takeover targets

    1:21 p.m. May 2, 2019

    - Michael Brush

  5. A Dozen 13D Deals

    1:50 a.m. March 9, 2019

    - Barron's Online

  6. Teva stock drops on guidance, manufacturing problems

    1:20 p.m. Feb. 11, 2018

    - Emma Court

  7. Down With Teva, Up With Portola

    11:03 a.m. Aug. 25, 2017

    - Barron's Online

  8. Charting the Market

    3:57 a.m. July 1, 2017

    - Barron's Online

  9. Alder BioPharma stock drops nearly 20% after positive late-stage migraine drug results

    10:13 a.m. June 27, 2017

    - Emma Court

  10. New migraine drugs have promise — and a $8,500 price tag

    12:02 p.m. June 9, 2017

    - Emma Court

  11. Three Top Picks in Smaller Pharma

    11:54 a.m. May 2, 2017

    - Barron's Online

  12. Alder BioPharmaceuticals started at overweight with $40 stock price target at J.P. Morgan

    8:40 a.m. Sept. 13, 2016

    - Tomi Kilgore

  13. Bull trend intact, latest S&P 500 breakout attempt underway

    12:30 p.m. Aug. 23, 2016

    - Michael Ashbaugh

  14. Bull trend intact, latest S&P 500 breakout attempt underway

    12:08 p.m. Aug. 23, 2016

    - Michael Ashbaugh

  15. Top U.S. Pharma Themes for the Second Half

    6:00 a.m. July 7, 2016

    - Barron's Online

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/aldr

Other News on ALDR

  1. Use Rising P/E Strategy to Grab 5 Winning Stocks

    5:42 a.m. Sept. 26, 2019

    - Zacks.com

  2. Merger Arbitrage Mondays - 2 New Acquisitions At Huge Premiums

    4:15 p.m. Sept. 24, 2019

    - Seeking Alpha

  3. Company News For Sep 17, 2019

    10:29 a.m. Sept. 17, 2019

    - Zacks.com

  4. ALDR, OSTK, PBF, SEMG and STOK among midday movers

    12:36 p.m. Sept. 16, 2019

    - Seeking Alpha

  5. Energy sector dominates premarket gainers

    9:22 a.m. Sept. 16, 2019

    - Seeking Alpha

  6. Alder Bio up 81% premarket on Lundbeck bid

    6:50 a.m. Sept. 16, 2019

    - Seeking Alpha

  7. Satsuma IPO: At Phase 3 Of Development

    6:32 p.m. Sept. 4, 2019

    - Seeking Alpha

  8. Satsuma Pharmaceuticals Files For U.S. IPO

    11:50 a.m. Aug. 22, 2019

    - Seeking Alpha

  9. NuCana Stops Patient Enrollment in Pancreatic Cancer Study

    11:08 a.m. Aug. 21, 2019

    - Zacks.com

  10. Loading more headlines...
/news/pressrelease/company/us/aldr

Press Releases on ALDR

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.